Alzinova Future Growth
Future criteria checks 2/6
Alzinova's revenue and earnings are forecast to decline at 52% and 57.5% per annum respectively while EPS is expected to decline by 56.4% per annum.
Key information
-57.5%
Earnings growth rate
-56.4%
EPS growth rate
Biotechs earnings growth | 39.8% |
Revenue growth rate | -52.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -84 | -84 | -84 | 1 |
12/31/2025 | N/A | -84 | -84 | -84 | 1 |
12/31/2024 | 52 | 7 | 4 | 11 | 2 |
12/31/2023 | 20 | -16 | -35 | -15 | N/A |
9/30/2023 | 17 | -16 | -31 | -13 | N/A |
6/30/2023 | 17 | -16 | -32 | -15 | N/A |
3/31/2023 | 14 | -15 | -32 | -17 | N/A |
12/31/2022 | 17 | -13 | -27 | -10 | N/A |
9/30/2022 | 16 | -11 | -26 | -10 | N/A |
6/30/2022 | 15 | -9 | -27 | -12 | N/A |
3/31/2022 | 17 | -8 | -25 | -8 | N/A |
12/31/2021 | 17 | -8 | -27 | -10 | N/A |
9/30/2021 | 18 | -7 | -25 | -7 | N/A |
6/30/2021 | 19 | -7 | -24 | -5 | N/A |
3/31/2021 | 16 | -6 | -20 | -5 | N/A |
12/31/2020 | 15 | -6 | -21 | -6 | N/A |
9/30/2020 | 13 | -7 | -21 | -8 | N/A |
6/30/2020 | 12 | -6 | -18 | -7 | N/A |
3/31/2020 | 11 | -7 | -17 | -6 | N/A |
12/31/2019 | 7 | -6 | -11 | -4 | N/A |
9/30/2019 | 5 | -5 | -11 | -6 | N/A |
6/30/2019 | 6 | -5 | -11 | -5 | N/A |
3/31/2019 | 8 | -5 | -11 | -3 | N/A |
12/31/2018 | 9 | -4 | -13 | -4 | N/A |
9/30/2018 | 11 | -3 | -13 | -2 | N/A |
6/30/2018 | 10 | -3 | -11 | -2 | N/A |
3/31/2018 | 8 | -2 | -9 | -2 | N/A |
12/31/2017 | 6 | -3 | -7 | -2 | N/A |
9/30/2017 | 5 | -3 | N/A | -2 | N/A |
6/30/2017 | 4 | -3 | N/A | -3 | N/A |
3/31/2017 | 5 | -4 | N/A | -3 | N/A |
12/31/2016 | 5 | -3 | N/A | -3 | N/A |
9/30/2016 | 5 | -4 | N/A | -3 | N/A |
6/30/2016 | 4 | -4 | N/A | -3 | N/A |
3/31/2016 | 2 | -3 | N/A | -3 | N/A |
12/31/2015 | 1 | -3 | N/A | -3 | N/A |
12/31/2014 | 1 | 0 | N/A | -1 | N/A |
12/31/2013 | 1 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALZ's earnings are forecast to decline over the next 3 years (-57.5% per year).
Earnings vs Market: ALZ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALZ is expected to become profitable in the next 3 years.
Revenue vs Market: ALZ's revenue is expected to decline over the next 3 years (-52% per year).
High Growth Revenue: ALZ's revenue is forecast to decline over the next 3 years (-52% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALZ's Return on Equity is forecast to be high in 3 years time